Publicacións en colaboración con investigadores/as de University of Milan (25)

2005

  1. Consensus statement: Medical management of acromegaly

    European Journal of Endocrinology, Vol. 153, Núm. 6, pp. 737-740

2003

  1. Diagnosis and treatment of acromegaly complications

    Journal of Endocrinological Investigation, Vol. 26, Núm. 12, pp. 1242-1247

2002

  1. Consensus: Guidelines for acromegaly management

    Journal of Clinical Endocrinology and Metabolism

2000

  1. Criteria for cure of acromegaly: A consensus statement

    Journal of Clinical Endocrinology and Metabolism, Vol. 85, Núm. 2, pp. 526-529

1985

  1. Activation of the cholinergic system and growth hormone release in the dog: Functional interactions with other neurotransmitters

    Acta Endocrinologica, Vol. 108, Núm. 1, pp. 36-43

  2. Prolactin in cerebrospinal fluid increases the synthesis and release of hypothalamic γ-aminobutyric acid

    Journal of Endocrinology, Vol. 106, Núm. 3, pp. 323-328

1984

  1. Daily fluctuations in the activity of the tuberoinfundibular GABAergic system and plasma prolactin levels

    Neuroendocrinology, Vol. 39, Núm. 4, pp. 367-370

  2. Regulation of prolactin secretion during suckling: involvement of the hypothalamo-pituitary GABAergic system

    Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology, Vol. 7, Núm. 5, pp. 481-487

1983

  1. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man

    Psychopharmacology, Vol. 80, Núm. 2, pp. 120-124

  2. Effect of agonists and antagonists of cholinergic neurotransmission on growth hormone release in the dog

    Acta Endocrinologica, Vol. 103, Núm. 1, pp. 15-20

  3. Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier

    Life Sciences, Vol. 32, Núm. 15, pp. 1751-1756

1981

  1. A role for dopamine in growth hormone regulation in the dog

    Endocrinology, Vol. 108, Núm. 4, pp. 1469-1475

  2. Central nervous system derived GABA influences plasma GABA concentrations and prolactin secretion

    British Journal of Pharmacology, Vol. 72, Núm. 1

  3. Dopamine-mimetic and antagonist drugs: Diagnostic and therapeutic applications in endocrine disorders

    Life Sciences, Vol. 29, Núm. 9, pp. 867-883

  4. Failure of different neuropharmacologic manipulations to trigger a paradoxical rise of growth hormone after glucose administration in the dog

    Pharmacological Research Communications, Vol. 13, Núm. 8, pp. 743-753

  5. Lack of tolerance in heroin-addicts to the neuroendocrine effects of an enkephalin analogue

    Life Sciences, Vol. 29, Núm. 5, pp. 493-501

  6. Mechanisms subserving the stimulatory and inhibitory components of γ-aminobutyric acid-ergic control of prolactin secretion in the rat

    Endocrinology, Vol. 109, Núm. 2, pp. 567-575

  7. Opiates act centrally on gh and prl release

    Endocrinology, Vol. 108, Núm. 6, pp. 2400-2402

  8. Proof for Histaminergic but Not for Adrenergic Involvement in the Growth Hormone-Releasing Effect of an Enkephalin Analog in the Dog

    Endocrinology, Vol. 108, Núm. 1, pp. 157-163

  9. Role of central nervous system-derived or circulating y-aminobutyric acid on prolactin secretion in the rat

    Endocrinology, Vol. 108, Núm. 4, pp. 1505-1510